BRCAnesswas described as a phenomenon in which HR deficiency occurs in a tumor not dueto a BRCA1 or BRCA2 germline mutation, but bymutations in other genes involved in HR (Lordand Ashworth, 2016). This evidence concerns the gene BRCA1 and neoplasm.